ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BSGM BioSig Technologies Inc

1.32
0.02 (1.54%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
BioSig Technologies Inc BSGM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.02 1.54% 1.32 09:00:00
개장가 저가 고가 종가 전일 종가
1.31 1.2701 1.39 1.37 1.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/04/202400:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
11/03/202422:00EDGAR2Form 8-K - Current report
05/03/202410:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202423:00EDGAR2Form 8-K - Current report
21/02/202400:00GLOBEBioSig Announces Reduction of its Workforce
15/02/202405:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202422:35EDGAR2Form 8-K - Current report
06/02/202422:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
03/02/202407:18EDGAR2Form 8-K/A - Current report: [Amend]
02/02/202407:25EDGAR2Form 8-K - Current report
01/02/202406:05EDGAR2Form 8-K - Current report
01/02/202401:15GLOBEBioSig Announces Reverse Stock Split
30/01/202422:52EDGAR2Form 8-K - Current report
30/01/202422:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
17/01/202406:15EDGAR2Form D - Notice of Exempt Offering of Securities
13/01/202407:28EDGAR2Form 8-K - Current report
09/01/202401:00EDGAR2Form 8-K - Current report
06/01/202406:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
05/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202303:37EDGAR2Form DEL AM - Delaying amendment
29/12/202306:30EDGAR2Form 8-K - Current report
29/12/202306:05EDGAR2Form S-3 - Registration statement under Securities Act of..
23/12/202306:30EDGAR2Form 8-K - Current report
19/12/202306:36EDGAR2Form 8-K - Current report
07/12/202307:07EDGAR2Form 8-K - Current report
07/12/202304:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
06/12/202307:29EDGAR2Form 8-K - Current report
05/12/202310:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:13EDGAR2Form DEF 14A - Other definitive proxy statements
22/11/202307:32EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202307:02EDGAR2Form 8-K - Current report
14/11/202306:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
13/11/202322:35EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
09/11/202306:05EDGAR2Form 8-K - Current report
07/11/202322:01EDGAR2Form 8-K - Current report
07/11/202322:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
04/11/202305:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/11/202305:30EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202321:00EDGAR2Form 8-K - Current report
02/11/202321:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
02/11/202320:17EDGAR2Form 8-K - Current report
01/11/202321:35EDGAR2Form 8-K - Current report
01/11/202321:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
25/10/202305:30EDGAR2Form PRE 14A - Other preliminary proxy statements
17/10/202306:00EDGAR2Form 8-K - Current report
28/09/202306:01EDGAR2Form 8-K - Current report
16/09/202305:54EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock